Halliwell Barry
Department of Biochemistry, Faculty of Medicine, National University of Singapore, Singapore.
Ann N Y Acad Sci. 2002 May;962:182-94. doi: 10.1111/j.1749-6632.2002.tb04067.x.
It is proposed that a primary mechanism leading to neuronal cell death in common neurodegenerative diseases is interference with proteasome function. This can involve genetic defects, direct inactivation of the proteasome (e.g., by reactive oxygen species), or overloading with proteins. The latter can be caused by excessive production of normal proteins or by the formation of poorly degradable proteins as a result of genetic mutations, faulty posttranslational modification, or protein modification by reactive oxygen or nitrogen species. Blockage of the proteasome leads to increased oxidative and nitrative stress, the latter apparently due to upregulation of nitric oxide synthase. Thus, agents that increase proteasome function may be generally neuroprotective, as may be NOS inhibitors. Proteasome inhibitors should be used with caution as therapeutic agents.
有人提出,在常见神经退行性疾病中导致神经元细胞死亡的主要机制是蛋白酶体功能受到干扰。这可能涉及基因缺陷、蛋白酶体的直接失活(例如,由活性氧引起)或蛋白质过载。后者可能是由于正常蛋白质的过度产生,或者是由于基因突变、错误的翻译后修饰或活性氧或氮物质对蛋白质的修饰而形成难以降解的蛋白质所致。蛋白酶体的阻断会导致氧化应激和硝化应激增加,后者显然是由于一氧化氮合酶的上调。因此,增强蛋白酶体功能的药物可能具有普遍的神经保护作用,一氧化氮合酶抑制剂也可能如此。蛋白酶体抑制剂作为治疗药物应谨慎使用。